This paper is in the following e-collection/theme issue:

Depression and Mood Disorders; Suicide Prevention (1691) Clinical Communication, Electronic Consultation and Telehealth (758) Sleep Monitoring, Sleep Quality, Sleep Disorders (268) Ecological Momentary Assessment (EMA) (405) mHealth for Screening (296) Telehealth and Telemonitoring (2088)

Published on in Vol 11 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/64578, first published .
Momentary Depression Severity Prediction in Patients With Acute Depression Who Undergo Sleep Deprivation Therapy: Speech-Based Machine Learning Approach

Momentary Depression Severity Prediction in Patients With Acute Depression Who Undergo Sleep Deprivation Therapy: Speech-Based Machine Learning Approach

Momentary Depression Severity Prediction in Patients With Acute Depression Who Undergo Sleep Deprivation Therapy: Speech-Based Machine Learning Approach

Authors of this article:

Lisa-Marie Hartnagel1 Author Orcid Image ;   Daniel Emden2 Author Orcid Image ;   Jerome C Foo3, 4, 5, 6 Author Orcid Image ;   Fabian Streit3, 7, 8 Author Orcid Image ;   Stephanie H Witt3 Author Orcid Image ;   Josef Frank3 Author Orcid Image ;   Matthias F Limberger1 Author Orcid Image ;   Sara E Schmitz1 Author Orcid Image ;   Maria Gilles7 Author Orcid Image ;   Marcella Rietschel3 Author Orcid Image ;   Tim Hahn2 Author Orcid Image ;   Ulrich W Ebner-Priemer1, 7 Author Orcid Image ;   Lea Sirignano3 Author Orcid Image
Article Authors Cited by (2) Tweetations Metrics

Journals

  1. Kaplan D, Alvarez S, Palitsky R, Choi H, Clifford G, Crozier M, Dunlop B, Grant G, Greenleaf M, Johnson L, Maples-Keller J, Levin-Aspenson H, Mascaro J, McDowall A, Pozzo N, Raison C, Zarrabi A, Rothbaum B, Lam W. Fabla: A voice-based ecological assessment method for securely collecting spoken responses to researcher questions. Behavior Research Methods 2025;57(9) View
  2. Müller C, Lenz B, Kornhuber J, Ebner-Priemer U, Schwarz E, Ersche K, Kiefer F, Spanagel R. Phase-sensitive individualized pharmacotherapy for alcohol use disorder. Neuropharmacology 2026;283:110745 View